Songmao Li, Qing Zhang, Li Zhang, Yongjian Ma, Feng Chen, Di Sun, Baicai Yang, Yanquan Li, Qianhui Hu, Fanghao Guo, Meiling Zhang, Wen Li
{"title":"番茄红素通过重建氧化还原平衡和调节Rock1表达提高玻璃化解冻卵母细胞的发育能力。","authors":"Songmao Li, Qing Zhang, Li Zhang, Yongjian Ma, Feng Chen, Di Sun, Baicai Yang, Yanquan Li, Qianhui Hu, Fanghao Guo, Meiling Zhang, Wen Li","doi":"10.1007/s10815-025-03640-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Oocyte vitrification is a critical technique for female fertility preservation; however, it is often accompanied by cryodamage that compromises subsequent embryo development. Moreover, limited research has assessed the long-term effects on offspring derived from vitrified oocytes. While antioxidants are frequently used to mitigate vitrification-induced oxidative stress and have been shown to enhance embryo development, their impact on implantation and offspring outcomes remains underexplored. Lycopene (LYC), a potent natural antioxidant, has not yet been evaluated in the context of oocyte vitrification.</p><p><strong>Methods: </strong>Oocytes were collected from 4-week-old C57/BL6J female mice. Fresh oocytes served as the negative control (n = 393). Vitrified-thawed oocytes were cultured in post-warming, IVF, and embryo culture media supplemented with 0 µM (positive control, n = 479), 0.05 µM (n = 485), 0.1 µM (n = 499), or 0.2 µM (n = 461) lycopene. Blastocysts from the fresh, vitrified, and LYC-0.1µM groups were transferred into the uterine horns of 3.5-dpc pseudopregnant 8-week-old ICR female mice to assess in vivo development.</p><p><strong>Results: </strong>Supplementation with 0.1 µM lycopene significantly improved the blastocyst formation rate in vitrified oocytes (75.56 ± 8.69% vs. 66.53 ± 6.94%, P = 0.029). Lycopene treatment elevated intracellular glutathione (GSH) levels (P < 0.001) and reduced reactive oxygen species (ROS) levels (P = 0.014). Notably, 0.1 µM lycopene modulated Rock1 expression during early embryogenesis, especially at the 4-cell stage, suggesting a potential role in developmental regulation. Despite improved preimplantation development, live birth rates following embryo transfer were similar between vitrified groups with or without lycopene, and both remained significantly lower than the fresh group (P = 0.008). None of the offspring had any apparent birth defect. No significant differences were observed among offspring in birth weight, growth trajectory, major organ morphology, gonadosomatic indices, or follicles counting among offspring.</p><p><strong>Conclusions: </strong>Lycopene exerts a protective effect against vitrification-induced oxidative stress by restoring redox homeostasis within oocytes and modulating Rock1 expression during early embryo development. Importantly, lycopene treatment did not compromise offspring health, supporting its potential as a safe adjunct to improve vitrification outcomes.</p>","PeriodicalId":15246,"journal":{"name":"Journal of Assisted Reproduction and Genetics","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lycopene improves the developmental competence of vitrified-thawed oocytes by reestablishing redox balance and modulating Rock1 expression.\",\"authors\":\"Songmao Li, Qing Zhang, Li Zhang, Yongjian Ma, Feng Chen, Di Sun, Baicai Yang, Yanquan Li, Qianhui Hu, Fanghao Guo, Meiling Zhang, Wen Li\",\"doi\":\"10.1007/s10815-025-03640-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Oocyte vitrification is a critical technique for female fertility preservation; however, it is often accompanied by cryodamage that compromises subsequent embryo development. Moreover, limited research has assessed the long-term effects on offspring derived from vitrified oocytes. While antioxidants are frequently used to mitigate vitrification-induced oxidative stress and have been shown to enhance embryo development, their impact on implantation and offspring outcomes remains underexplored. Lycopene (LYC), a potent natural antioxidant, has not yet been evaluated in the context of oocyte vitrification.</p><p><strong>Methods: </strong>Oocytes were collected from 4-week-old C57/BL6J female mice. Fresh oocytes served as the negative control (n = 393). Vitrified-thawed oocytes were cultured in post-warming, IVF, and embryo culture media supplemented with 0 µM (positive control, n = 479), 0.05 µM (n = 485), 0.1 µM (n = 499), or 0.2 µM (n = 461) lycopene. Blastocysts from the fresh, vitrified, and LYC-0.1µM groups were transferred into the uterine horns of 3.5-dpc pseudopregnant 8-week-old ICR female mice to assess in vivo development.</p><p><strong>Results: </strong>Supplementation with 0.1 µM lycopene significantly improved the blastocyst formation rate in vitrified oocytes (75.56 ± 8.69% vs. 66.53 ± 6.94%, P = 0.029). Lycopene treatment elevated intracellular glutathione (GSH) levels (P < 0.001) and reduced reactive oxygen species (ROS) levels (P = 0.014). Notably, 0.1 µM lycopene modulated Rock1 expression during early embryogenesis, especially at the 4-cell stage, suggesting a potential role in developmental regulation. Despite improved preimplantation development, live birth rates following embryo transfer were similar between vitrified groups with or without lycopene, and both remained significantly lower than the fresh group (P = 0.008). None of the offspring had any apparent birth defect. No significant differences were observed among offspring in birth weight, growth trajectory, major organ morphology, gonadosomatic indices, or follicles counting among offspring.</p><p><strong>Conclusions: </strong>Lycopene exerts a protective effect against vitrification-induced oxidative stress by restoring redox homeostasis within oocytes and modulating Rock1 expression during early embryo development. Importantly, lycopene treatment did not compromise offspring health, supporting its potential as a safe adjunct to improve vitrification outcomes.</p>\",\"PeriodicalId\":15246,\"journal\":{\"name\":\"Journal of Assisted Reproduction and Genetics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Assisted Reproduction and Genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10815-025-03640-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Assisted Reproduction and Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10815-025-03640-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Lycopene improves the developmental competence of vitrified-thawed oocytes by reestablishing redox balance and modulating Rock1 expression.
Purpose: Oocyte vitrification is a critical technique for female fertility preservation; however, it is often accompanied by cryodamage that compromises subsequent embryo development. Moreover, limited research has assessed the long-term effects on offspring derived from vitrified oocytes. While antioxidants are frequently used to mitigate vitrification-induced oxidative stress and have been shown to enhance embryo development, their impact on implantation and offspring outcomes remains underexplored. Lycopene (LYC), a potent natural antioxidant, has not yet been evaluated in the context of oocyte vitrification.
Methods: Oocytes were collected from 4-week-old C57/BL6J female mice. Fresh oocytes served as the negative control (n = 393). Vitrified-thawed oocytes were cultured in post-warming, IVF, and embryo culture media supplemented with 0 µM (positive control, n = 479), 0.05 µM (n = 485), 0.1 µM (n = 499), or 0.2 µM (n = 461) lycopene. Blastocysts from the fresh, vitrified, and LYC-0.1µM groups were transferred into the uterine horns of 3.5-dpc pseudopregnant 8-week-old ICR female mice to assess in vivo development.
Results: Supplementation with 0.1 µM lycopene significantly improved the blastocyst formation rate in vitrified oocytes (75.56 ± 8.69% vs. 66.53 ± 6.94%, P = 0.029). Lycopene treatment elevated intracellular glutathione (GSH) levels (P < 0.001) and reduced reactive oxygen species (ROS) levels (P = 0.014). Notably, 0.1 µM lycopene modulated Rock1 expression during early embryogenesis, especially at the 4-cell stage, suggesting a potential role in developmental regulation. Despite improved preimplantation development, live birth rates following embryo transfer were similar between vitrified groups with or without lycopene, and both remained significantly lower than the fresh group (P = 0.008). None of the offspring had any apparent birth defect. No significant differences were observed among offspring in birth weight, growth trajectory, major organ morphology, gonadosomatic indices, or follicles counting among offspring.
Conclusions: Lycopene exerts a protective effect against vitrification-induced oxidative stress by restoring redox homeostasis within oocytes and modulating Rock1 expression during early embryo development. Importantly, lycopene treatment did not compromise offspring health, supporting its potential as a safe adjunct to improve vitrification outcomes.
期刊介绍:
The Journal of Assisted Reproduction and Genetics publishes cellular, molecular, genetic, and epigenetic discoveries advancing our understanding of the biology and underlying mechanisms from gametogenesis to offspring health. Special emphasis is placed on the practice and evolution of assisted reproduction technologies (ARTs) with reference to the diagnosis and management of diseases affecting fertility. Our goal is to educate our readership in the translation of basic and clinical discoveries made from human or relevant animal models to the safe and efficacious practice of human ARTs. The scientific rigor and ethical standards embraced by the JARG editorial team ensures a broad international base of expertise guiding the marriage of contemporary clinical research paradigms with basic science discovery. JARG publishes original papers, minireviews, case reports, and opinion pieces often combined into special topic issues that will educate clinicians and scientists with interests in the mechanisms of human development that bear on the treatment of infertility and emerging innovations in human ARTs. The guiding principles of male and female reproductive health impacting pre- and post-conceptional viability and developmental potential are emphasized within the purview of human reproductive health in current and future generations of our species.
The journal is published in cooperation with the American Society for Reproductive Medicine, an organization of more than 8,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology.